Acumen Pharmaceuticals, Inc.
ABOSNasdaqCIK 1576885HealthcareFiscal year ends Dec 31
Reports and events: 89 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2616:03 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-067276 |
| 2026-10-2607:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-067129 |
| 2026-09-1609:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-062137 |
| 2026-08-1216:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-056199 |
| 2026-08-1207:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-055940 |
| 2026-06-1607:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-043416 |
| 2026-06-0316:43 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-040447 |
| 2026-05-1217:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-034204 |
| 2026-05-1207:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-033868 |
| 2026-04-2316:30 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001628280-26-026870 |
| 2026-03-2616:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-021413 |
| 2026-03-2607:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-021189 |
| 2026-03-1716:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-029538 |
| 2026-03-1607:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-017885 |
| 2026-01-1208:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001774 |
| 2025-11-1216:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001576885-25-000104 |
| 2025-11-1207:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000102 |
| 2025-11-1008:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-050800 |
| 2025-08-1217:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001576885-25-000093 |
| 2025-08-1208:42 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000091 |
| 2025-07-1507:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000087 |
| 2025-06-0516:37 ET | 8-K | 5.07 Shareholder vote results | 0001576885-25-000072 |
| 2025-05-1316:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001576885-25-000065 |
| 2025-05-1307:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000062 |
| 2025-04-2316:23 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001576885-25-000057 |
| 2025-03-3116:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-009256 |
| 2025-03-2716:34 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001576885-25-000049 |
| 2025-03-2707:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000044 |
| 2024-11-1216:29 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001576885-24-000098 |
| 2024-11-1207:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000096 |
| 2024-08-1316:42 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001576885-24-000092 |
| 2024-08-1307:48 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000090 |
| 2024-06-0516:36 ET | 8-K | 5.07 Shareholder vote results | 0001576885-24-000067 |
| 2024-05-1416:47 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001576885-24-000064 |
| 2024-05-1407:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000061 |
| 2024-04-2216:30 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001576885-24-000055 |
| 2024-03-2609:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001576885-24-000047 |
| 2024-03-2607:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576885-24-000044 |
| 2024-03-1908:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000039 |
| 2024-02-0107:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000032 |
| 2024-01-1208:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000018 |
| 2024-01-0808:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000015 |
| 2023-12-0407:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000068 |
| 2023-11-1317:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000065 |
| 2023-11-1316:21 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001576885-23-000062 |
| 2023-11-1307:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000058 |
| 2023-11-0917:59 ET | 8-K | 1.01 Entry into a material agreement | 0001576885-23-000056 |
| 2023-08-0816:12 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001576885-23-000050 |
| 2023-08-0807:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000047 |
| 2023-07-2516:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-083859 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 07:07 ET. Listed shows no prices and gives no investment advice.